Leptin directly activates macrophages and lymphocytes, but the role of leptin in neutrophil activation and migration is still controversial. Here, we investigate the in vivo mechanisms of neutrophil migration induced by leptin. The intraperitoneal injection of leptin (1 mg/kg) induces a time-and concentration-dependent neutrophil influx. We did not observe the enhancement of lipid bodies/droplets in neutrophils, after leptin treatment, as we had observed previously in peritoneal macrophages. The participation of leukotriene B4 (LTB4) in neutrophil recruitment triggered by leptin was investigated using different strategies. Leptin-induced neutrophil recruitment occurs both in the absence of 5-lipoxygenase activity in 5-lipoxygenase (5-LO) −/− mice and after the administration of either 5-LO inhibitor (Zileuton) or the LTB4 receptor antagonist (U-75302). Moreover, no direct induction of LTB4 by leptin could be observed. Neutrophil influx could not be prevented by the mammalian target of rapamycin (mTOR) inhibitor, rapamycin, contrasting with the leptin-induced signaling for lipid body formation in macrophage that is mTOR-dependent. Leptin administration led to tumor necrosis factor-alpha (TNFα) production by the peritoneal cells both in vivo and in vitro. In addition, neutrophil recruitment was inhibited in tumor necrosis factor receptor 1 (TNFR1 inTrODUcTiOn A growing body of evidence indicates that leptin is a key modulator of the homeostasis of the immune system (1, 2) . Although effective leptin therapy for treating obesity and diabetes is not established, mainly due to leptin resistance in obese patients, there are several clinical trials for combined therapies to improve the treatment of obesity-related conditions and lipodystrophy (3) (4) (5) (6) . In fact, the leptin analog Metreleptin was approved by the U.S. Food and Drug Administration for the long-term treatment of lipodystrophy (3, 7) . Leptin is known as an adipokine and modulator of the immune system (8) . However, the mechanism of leptin-induced leukocyte activation and recruitment in vivo needs further investigation. Leptin has been shown to act as a direct activator of macrophages, lymphocytes, and other leukocytes (9) . Neutrophils, however, do not present the full-length leptin receptor, LepRb. This isoform is responsible for the described intracellular effects of leptin in different cell types. Leptin indirectly induces the in vitro neutrophil expression of CD11b in response to the direct stimulation of macrophages (10) . When investigating the in vivo effects of leptin on peritoneal macrophages and lipid droplet formation, we detected the presence of neutrophils in the peritoneal lavage (11) . Leptin is known to be important for a proper response to infections and immunological homeostasis, but little is known about the in vivo modulation of neutrophil migration by leptin (12) . Leptin is acutely enhanced in infections and chronically enhanced during obesity, and neutrophils play an important role on the innate immune response (13, 14) . We decided therefore to investigate how leptin can activate and induce inflammatory mediators indirectly causing neutrophil migration in vivo, with potential implications for a number of inflammatory conditions in different diseases. TNFα was described to act on the priming step of neutrophil activation, while chemokines as well as leukotriene B4 (LTB4) can induce neutrophil adhesion and migration (15) . TNFα was also found contributing to neutrophil recruitment stimulated by the chemokine CXCL1/KC, a direct chemoattractant for neutrophils (16) . Here, we show that exogenous leptin induces in vivo migration and persistent neutrophil accumulation in the peritoneal cavity, through a mechanism largely dependent on TNFα and CXCL1 but independent of LTB4 production and signaling.
MaTerials anD MeThODs

Materials
Murine-recombinant leptin, rabbit anti-mouse CXCL1 antibody (catalog # 250-11), and control rabbit IgG (catalog # 500-P00) were purchased from Peprotech, Inc. (Rocky Hill, NJ, USA 
In Vivo leptin Treatments
The in vivo treatments were performed as previously described (11) . Briefly, following the intraperitoneal (i.p.) administration of leptin (0.25, 0.5, 1, and 2 mg/kg, depending on the experiment) or vehicle (sterile, apirogenic saline), animals were euthanized at different time points (1, 6 , or 24 h, as specified in each experiment). Alternatively, animals received three i.p. injections of rapamycin (12.5 μg/kg), or vehicle, 12 h before, 15 min before, and 12 h after the injection of leptin or saline, and the peritoneal lavage was harvested after 24 h. This treatment was established by us and was proved to be effective for the inhibition of leptin-induced lipid droplets in peritoneal macrophages (11) . We also evaluated the effect of i.p. pretreatments, 15 min prior to leptin treatment, with the phospholipase A2 inhibitor, Zileuton (60 μg/cavity), or the LTB4 receptor BLT1-specific inhibitor, U-75302 (5 mg/kg). These drugs were administered according to data from previous works from our group and others (22) (23) (24) (25) (26) (27) (28) . To block CXCL1, the antibody against CXCL1 (3 μg/animal) or the isotype control (diluted in sterile saline) was injected into the peritoneal cavity, 10 min before the leptin injection. After the time specified in each experiment, the peritoneal cells were harvested as follows. The peritoneal cavity was rinsed with HBSS (Hank's balanced salted solution, 3 mL/cavity), and a volume of approximately 2.5 mL was recovered. Samples were diluted in Turk fluid (2% acetic acid) for total leukocyte counts using Neubauer chambers. Differential leukocyte counting was performed in cytospin smears stained by May-Grünwald-Giemsa, a classical staining for the differential identification of leukocytes (mononuclear cells, neutrophils, and eosinophils) (29) . As a control of vascular integrity, we assured that leptin injection does not modify peritoneal lavage protein concentrations There is no difference in the total protein concentration between the samples at 6 h after injection of saline (0.754 ± 0.032 mg/mL) or leptin (0.729 ± 0.048 mg/mL), or at 24 h after injection of saline (0.776 ± 0.014 mg/mL) or leptin (0.749 ± 0.037 mg/mL).
In Vitro leptin incubation
The peritoneal cells including the macrophages were obtained from naïve C57Bl/6 mice, by peritoneal lavage with HBSS (5 mL). Cells were transferred to polypropylene tubes (1 × 10 6 cells/mL) and then incubated with leptin (20 nM) for 4 h, under 37°C, 5% CO2 atmosphere in RPMI 1604 medium. After incubation, tubes were centrifuged for supernatant collection. Cell viability was always >85% as determined by Trypan blue exclusion. For neutrophils were obtained as previously described (30) . Briefly, the bone marrow from femurs and tibias was washed, and neutrophils were purified in a discontinuous Percoll gradient. Neutrophil viability was greater than 95% as assessed by the Trypan blue exclusion test, and purity was greater than 98% as analyzed by microscopy using Hemacolor staining (Merck, Darmstadt, Germany).
Kc, TnF, leptin, and lTB 4 Quantification
Peritoneal lavage or in vitro supernatants were analyzed for TNFα, CXCL1/KC, and LTB4. TNFα and CXCL1 ELISA were performed with Duo Set kit, according to manufacturer's protocol (R&D Systems, Minneapolis, MN, USA) and LTB4 with enzyme immuno assay (EIA) kit (Cayman Chemical, Ann Arbor, MI, USA). For the investigation of the presence of intracellular LTB4, we used the previously described Eicosacell protocol (31) . Briefly, leukocytes were recovered from peritoneal cavities and immediately submitted to fixation and permeabilization with 0.5% 1-ethyl-3-(3-dimethylamino-propyl) carbodiimide (Sigma) in HBSS. After that, a common immunodetection protocol was performed using the following antibodies: the primary antibody anti-LTB4 (Cayman Chemical) or irrelevant IgG and the secondary antibody Alexa 488-labeled anti-rabbit IgG. Images were obtained using an Olympus BX51 fluorescence microscope and equipped with a Plan Apo ×100 objective and a DP72 camera (Olympus Optical, Japan) in conjunction with Cell F Imaging Software (Olympus Life Science Europe, Germany).
statistical analysis
Data were reported as the mean ± standard error of the mean (SEM). Data were statistically analyzed by the analysis of variance with Newman-Keuls-Student test, or Student's t-test. Differences were considered to be significant when p ≤ 0.05 (see figure legends). +/+ or PI3Kγ −/− mice were injected intraperitoneally with leptin (1 mg/kg) or saline. Neutrophils were counted in the peritoneal wash at 24 h after leptin injection. (B) C57Bl/6 mice received rapamycin treatment (12.5 µg/kg per injection) 12 h before, 15 min before, and 12 h after leptin injection. Each bar represents the mean ± SEM, n = 3-6 (a) and 6-8 (B). The experiments were performed at least three times. Data were analyzed by Newman-Keuls-Student test. *Statistically significant difference (p < 0.05) between leptin-stimulated and saline groups. Moreover, we confirmed the absence of a direct effect of leptin on neutrophils by in vitro neutrophil adhesion experiments ( Figure S2 in Supplementary Material). Even with very high leptin concentrations (up to 200 nM), no adhesion was observed.
In our preparation, we ensured >98% purity of neutrophils as previously described (30) .
leptin-induced neutrophil Migration is requisitely Dependent on TnFα
It had been previously demonstrated that leptin indirectly activates human neutrophils (10) . This work showed that neutrophil CD11b expression can be enhanced in response to TNFα produced by leptin-stimulated monocytes in vitro. We confirmed that leptin induced TNFα production by the peritoneal cells in vitro (Figure 2A) . Moreover, leptin injection into the peritoneal cavity induced in vivo TNFα production ( Figure 2B) . In order to investigate the role of TNFα receptor on leptin-induced neutrophil recruitment in vivo, TNFR1 knockout mice (TNFR1 −/− ) or WT (TNFR1 +/+ ) animals (C57Bl/6) were used. As demonstrated in Figure 2C , leptin was unable to induce neutrophil accumulation in TNFR1 −/− mice, but interestingly, TNFR1 is not necessary for the effect of leptin in inducing lipid droplets in macrophages ( Figure S3 in Supplementary Material). Leptin induced lipid body formation in peritoneal macrophages from TNFR1 −/− mice, similar to what was observed in WT (TNFR1 +/+ mice). Thus, leptininduced neutrophil migration is dependent on TNFR1 signaling, but macrophage lipid body formation occurs independently of this TNFα receptor.
leptin-induced neutrophil recruitment is Dependent on the Pi3Kγ Pathway
Several studies have demonstrated the importance of PI3K, specifically PI3Kγ, in leukocyte migration and activation in vivo (19, (36) (37) (38) (39) . To determine the role of PI3Kγ in the acute response induced by leptin, we examined neutrophil in WT mice or mice genetically deficient in PI3Kγ (PI3Kγ
), 24 h after leptin i.p. administration. Leptin-induced accumulation of neutrophils in the peritoneal cavity was completely inhibited in PI3Kγ
−/− mice in comparison to that in WT control animals ( Figure 3A) . Thus, the PI3Kγ-signaling pathway is required for leptin-induced neutrophil recruitment. leptin-induced neutrophil recruitment is independent on mTOr Pathway
We showed previously that mTOR was required for the effects of leptin on lipid droplets formation in macrophages both in vitro and in vivo (11) . Others reported that the mTOR pathway was important for GM-CSF-dependent neutrophil activation in vitro (40) . We investigated here the functional role of the mTOR pathway for the in vivo leptin-induced neutrophil activation and recruitment. We used the previously described treatment with rapamycin, a specific inhibitor and probe for mTOR activity (11, 41) . The treatment of mice with rapamycin failed to modify leptin-induced neutrophil accumulation after 24 h (Figure 3B ).
leptin-induced neutrophil Migration is independent of lTB 4
It had been shown that the lipid mediator LTB4 directly exerts a chemoattractive effect on neutrophils in inflammatory conditions (42, 43) . We performed several in vivo experiments in order to evaluate the role of LTB4 in neutrophil migration stimulated by leptin. First, an EIA assay was performed to detect LTB4 presence on peritoneal supernatants obtained after leptin i.p. injection. There was no difference in the concentration of LTB4 between saline and 1-, 6-, or 24-h leptin-stimulated groups ( Figure 4A ). It could be that LTB4 was produced but not released from the cell; therefore, we performed the Eicosacell assay. We did not observe intracellularly retained LTB4 in the peritoneal cells submitted to the Eicosacell assay as performed before by our group (data not shown) (31) . We also investigated the importance of the LTB4 synthesis enzyme, 5-LO for neutrophil migration. Therefore, 5-LO +/+ or 5-LO −/− mice were injected with leptin in the peritoneal cavity (1 mg/kg), and neutrophil migration was investigated. As shown in Figure 4B , leptin induced neutrophil migration (24 h) in 5-LO knockout mice. The pharmacological inhibition of LTB4 synthesis by Zileuton (60 µg/animal i.p.) and signaling on the receptor BTL1 by U-75302 (5 mg/kg i.p.) were tested. Figure 4C shows that peritoneal neutrophils migrate in response to leptin injection, despite pharmacological pretreatments. These results demonstrate that LTB4 does not participate in leptin-induced neutrophil recruitment.
leptin-induced neutrophil Migration is Dependent on cXcl1
CXCL1 is known to mediate the neutrophil migration through the activation of CXCR2, a PI3Kγ-dependent receptor (44) . Neutrophil migration can also be promoted by CCL3/MIP-1α signaling through CCR1, a PI3Kγ-dependent receptor (45) . Because our result in Figure 3A showed that leptin-induced neutrophil recruitment is dependent on PI3Kγ, we investigated the chemokines CXCL1 and CCL3 as possible mediators for this effect. We observed that CXCL1 is secreted by the peritoneal cells stimulated by leptin both in vitro and in vivo (Figures 5A,B) . Anti-CXCL1-neutralizing antibodies were used in vivo as a pretreatment before leptin injection. A partial but significant inhibition of neutrophil migration to peritoneal cavity was observed ( Figure 5C) . We investigated the participation of the chemokine CCL3 using the CCL3 knockout mice (CCL3
−/−
). Mice were injected with leptin i.p. and, as seen in Figure 5D , neutrophil recruitment was not altered when compared to WT mice (CCL3 +/+ ). Taken together, our data show that leptin activates the peritoneal cells to induce neutrophil migration in a specific CXCL1-dependent manner.
DiscUssiOn
We demonstrated here that the in vivo administration of leptin significantly induces neutrophil recruitment to the peritoneal cavity. We propose here that this is an indirect effect of leptin, which requires peritoneal resident cell activation with the production of TNFα and CXCL1, mostly by resident monocytes/ macrophages. It was shown before that leptin induces TNFα production by macrophages, and under different inflammatory stimuli, peritoneal macrophages produce TNFα and CXCL1 that are important for neutrophil migration (10, 16, 46) . Leptin contribution to the modulation of neutrophil activation has been controversial because neutrophils present LepRa but lack LepRb (10, 47) . It was suggested that leptin could stimulate chemotaxis and the release of hydrogen peroxide by human neutrophils (48) . Others demonstrated that leptin could only indirectly trigger increased CD11b expression on human neutrophils by the induction of TNFα release from monocytes in vitro, and highly purified neutrophils (more than 98%) do not produce TNF under leptin stimulation (10) . It was also suggested that leptin could inhibit neutrophil apoptosis in a LepRa-dependent manner (49) . More recently, it was demonstrated that only extremely high concentrations of leptin could drive direct changes on neutrophil activation or the inhibition of apoptosis (above 3-25 µg/mL; 200-1,600 nM) (50). Kamp et al. concluded that there is no convincing evidence that physiological leptin concentrations could directly activate neutrophils. Accordingly, we found no significant activation of adhesion, even with 200 nM ( Figure S2 in Supplementary Material). These previous studies to evaluate the neutrophil capacity to migrate were performed in vitro. We decided to study the in vivo mechanisms for neutrophil migration under exogenous leptin administration. Our data show in vivo leptin-induced neutrophil recruitment and suggest an indirect activation of other resident cells. Lipid droplet formation is associated with leukocyte activation in different inflammatory models (33, 35, 51, 52) . Interestingly, we found that there was no enhanced lipid droplet formation in leptin-dependent-migrating neutrophils ( Figure S1 in Supplementary Material). We suggest here that leptin effects are not sufficient for the complete activation of neutrophils in vivo. The contribution of LTB4 to inflammation progression is well known. This lipid mediator is both an important neutrophil chemotaxis inducer, the activator of phagocytosis, and the main eicosanoid produced by neutrophils under diverse pro-inflammatory stimuli ((24, 53-57)). We had previously shown that leptin-stimulated peritoneal macrophages have a higher capacity to produce LTB4 following calcium ionophore activation (11) . The absence of LTB4 in the peritoneal cavity, shown in Figure 4A , provides evidence that the migrating neutrophils, after leptin stimulation, are not fully activated. Moreover, leptin induced neutrophil recruitment despite the genetic 5-LO null background, the pharmacological inhibition of 5-LO, or the pharmacological blockage of BLT1 (Figure 4) . These results rule out an involvement of LTB4 in leptininduced neutrophil activation and recruitment in vivo.
It was known that TNFα induces CD11b expression on neutrophils, an important integrin component that participates in intraluminal adhesion and crawling in the site of inflammation (10, 58) . We show here that the leptin effect on neutrophil migration is mediated by TNFα signaling through TNFR1. Indeed, leptin failed to recruit neutrophils to the peritoneal cavity in mice genetically deficient in TNFR1. An indirect action of leptin on neutrophils mediated by TNFα supports the involvement of this pathway in acute inflammatory responses. Chemokines, produced by resident cells under TNFα stimulation, such as the CXCL1/KC, the mouse analog to human IL-8, have been shown to induce the recruitment of neutrophils to inflammatory sites (16) . Moreover, leptin induces CXCL1 in epithelial cells (59) . Here, we show that resident peritoneal cells secrete CXCL1 after leptin stimulation, both in vivo and in vitro, and CXCL1 neutralization partially inhibits neutrophil migration. We conclude that leptin-induced neutrophil recruitment is dependent on the CXCL1 chemokine produced by the peritoneal cells. It was recently described that adipose stromal cells can be recruited from white adipose tissue to tumor environments through CXCL1 signaling, suggesting that the increased aggressiveness of certain cancers is linked to white adipose tissue overgrowth in obesity (60) . Our data offer a possible explanation for the role of leptin in tumor cell recruitment during obesity, when high levels of leptin production by white adipose tissue are observed. The PI3Kγ-signaling pathway was shown to be relevant for neutrophil recruitment induced by CXCL1 in vivo in specific sites of inflammatory stimuli. Neutrophil recruitment to bronchoalveolar space induced by CXCL1 was prevented in PI3Kγ −/− mice (44) . However, these authors showed that the administration of CXCL1 in the cremaster muscle of PI3Kγ −/− or WT mice induced similar increases in neutrophil rolling, adhesion, and transmigration. Our data show that leptin-induced neutrophil migration to the peritoneal cavity is prevented in PI3Kγ −/− mice. We suggest that this may be caused by CXCL1 signaling through PI3Kγ, since PI3K-regulatory subunits differentially participate in neutrophil migration either in vivo and in vitro (61) . It may also reflect the combination of PI3Kγ activation in endothelium and neutrophils, which is required for leukocyte trafficking to sites of inflammation (62) . Based on our findings and previous published data, we conclude that PI3Kγ have both direct and indirect effects on neutrophil recruitment, since PI3Kγ is part of the signaling pathway activated by CXCL1 in neutrophils and is important for the leptin-induced activation of macrophages (11, 44, 63) .
Other chemokines were shown to be important for neutrophil recruitment, such as CCL3, and both insulin and TNFα could prime the neutrophils for CCL3/MIP-1α-dependent migration (64, 65) . Different from insulin, we observed that the leptin effect was not dependent on CCL3 since neutrophil migration was maintained on the CCL3-deficient mice ( Figure 5C ).
We previously demonstrated that leptin induced lipid droplet formation in peritoneal macrophages in a PI3K/mTOR-dependent manner (11) . Interestingly, the lipid droplet induction by leptin on resident peritoneal macrophages is not dependent on TNFα signaling because this effect was maintained in the TNFR1 −/− ( Figure S3 in Supplementary Material). Therefore, leptin induces TNFα-and CXCL1-dependent neutrophil migration, by a distinct pathway from lipid droplet formation in the peritoneal cells.
In the immune system, mTOR is involved in signaling downstream from different inflammatory stimuli. Phosphatidic acid and LPS are examples of leukocyte activation inducers that depend on mTOR activation (66) (67) (68) , and also GM-CSFinduced neutrophil migration was shown to be inhibited by rapamycin (40) . The mTOR pathway is important for the PAFinduced activation of neutrophils, inducing the translation of the cytokine IL-6 receptor (69). Nevertheless, we showed here that the indirect effect of leptin-induced migration of neutrophils is independent of the TORC1 pathway (rapamycin-inhibited mTOR complex). Rapamycin is a proapoptotic drug for different cells including neutrophils. Since rapamycin does not alter neutrophil accumulation after 24 h (Figure 3) , we suggest that the mTOR-dependent inhibition of apoptosis is not the main effect of leptin on neutrophils in vivo.
It has been shown that LPS-induced systemic inflammation presents neutrophils transmigration into the brain in a leptindependent manner (70, 71) . Our data are in agreement to these in vivo results, but we show that leptin can promote in vivo neutrophil migration independently of LPS-inflammatory response. In a lung injury model, the intranasal administration of leptin counteracted some LPS effects in neutrophils (72) . Such results are in apparent contrast with our hypothesis and data. We think that these results are due to tissue-specific effects. We evaluated the peritoneal cavity, while Landgraf et al. analyzed lung tissue, where leptin can directly activate the alveolar epithelium. We recently studied the direct effects of leptin intestinal epithelial cells and observed an enhancement of TGFβ that could be responsible for inhibitory effects on the tissue macrophages (59) . It has also been suggested that there may be different subsets of neutrophils (73) . These different neutrophil subsets may then have diverse responses toward direct or indirect leptin stimulation. Therefore, it would be very interesting to further explore the differential effects of leptin on leukocytes migration in distinct tissues, administration sites, and different neutrophil subsets.
Our data reveal the importance of leptin for neutrophil migration to sites of inflammation. We argue that it is crucial to understand these effects in great detail, in particular because of the prescription of recombinant leptin in different human conditions.
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